Pfizer Vaccine Clinical Trials Poorly Designed From the Start, Analysis Shows
The Canadian COVID Care Alliance assembled a presentation that demonstrates how Pfizer’s purported randomized placebo-controlled, double-blinded study veered away from methodologies that would have definitively answered questions about the vaccine’s safety and efficacy.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed